The REZA BAND applies slight pressure to the neck to reduce laryngopharyngeal reflux symptoms. In clinical trials, 86 percent of patients were found to have significant symptom reduction after two weeks, according to the report.
Reza Shaker, MD, chief of gastroenterology and hepatology at Froedtert & The Medical College of Wisconsin in Milwaukee, is one of the founders of Somna Therapeutics.
More articles on gastroenterology:
26 gastroenterologists making headlines – March 10, 2015
Exact Sciences, Ironwood Pharmaceuticals partner for promotion of Cologuard
Gastroenterology technology company to know: Exalenz Bioscience
